🔎 Trials Near Me

홈 › 비소세포폐암 › 아이다호

아이다호의 비소세포폐암 임상 시험

비소세포폐암 관련 연구 18개가 아이다호 내 여러 지역에서 참여자를 모집하고 있습니다.

아이다호의 도시

공식 연구 텍스트(영어)

Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial

  • Kootenai Health - Coeur d'Alene, Coeur d'Alene
  • Kootenai Clinic Cancer Services - Post Falls, Post Falls
  • Kootenai Clinic Cancer Services - Sandpoint, Sandpoint
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 10. 5. 업데이트됨 · NCT07388524

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

  • Saint Alphonsus Cancer Care Center-Boise, Boise
  • Saint Alphonsus Cancer Care Center-Caldwell, Caldwell
  • Kootenai Health - Coeur d'Alene, Coeur d'Alene
  • 외 3개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 10. 5. 업데이트됨 · NCT04267848

A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

  • Beacon Cancer Care ( Site 0127), Post Falls
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT06623422

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

  • Saint Luke's Cancer Institute - Boise, Boise
  • Kootenai Health - Coeur d'Alene, Coeur d'Alene
  • Saint Luke's Cancer Institute - Fruitland, Fruitland
  • 외 5개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 10. 1. 업데이트됨 · NCT06498635

Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

  • Saint Alphonsus Cancer Care Center-Boise, Boise
  • Saint Alphonsus Cancer Care Center-Caldwell, Caldwell
  • Kootenai Health - Coeur d'Alene, Coeur d'Alene
  • 외 4개
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT03191149

A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%

  • Local Institution - 0509, Coeur d'Alene
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT06561386

Prospective External Control Cohort In Patients With Newly Diagnosed Advanced or Metastatic EGFR Mutant Non-Small Cell Lung Cancer

  • Kootenai Clinic Cancer Services Coeur d'Alene, Coeur d'Alene
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07028489

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

  • Research Site, Boise
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 18. 업데이트됨 · NCT06692738

Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations

  • Saint Alphonsus Regional Medical Center - Boise, Boise
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 17. 업데이트됨 · NCT07195695

Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer

  • Saint Luke's Cancer Institute - Boise, Boise
  • Saint Luke's Cancer Institute - Fruitland, Fruitland
  • Saint Luke's Cancer Institute - Meridian, Meridian
  • 외 1개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 7. 14. 업데이트됨 · NCT06686771

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

  • Saint Alphonsus Cancer Care Center-Boise, Boise
  • Saint Alphonsus Cancer Care Center-Caldwell, Caldwell
  • Kootenai Health - Coeur d'Alene, Coeur d'Alene
  • 외 3개
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 6. 3. 업데이트됨 · NCT05642572

Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)

  • Saint Alphonsus Health System, Boise
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 5. 19. 업데이트됨 · NCT07154706

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

  • Saint Alphonsus Cancer Care Center-Boise, Boise
  • Saint Alphonsus Cancer Care Center-Caldwell, Caldwell
  • Kootenai Health - Coeur d'Alene, Coeur d'Alene
  • 외 3개
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 5. 6. 업데이트됨 · NCT06116682

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

  • Saint Alphonsus Cancer Care Center-Boise, Boise
  • Saint Luke's Cancer Institute - Boise, Boise
  • Saint Alphonsus Cancer Care Center-Caldwell, Caldwell
  • 외 8개
피험자 모집 중2/3상
18세 이상 · 모든 성별 · 2026. 5. 5. 업데이트됨 · NCT06616584

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

  • Saint Alphonsus Cancer Care Center-Boise, Boise
  • Saint Alphonsus Cancer Care Center-Caldwell, Caldwell
  • Kootenai Health - Coeur d'Alene, Coeur d'Alene
  • 외 3개
피험자 모집 중2상
18 Minutes · 모든 성별 · 2026. 5. 5. 업데이트됨 · NCT06031688

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

  • Saint Alphonsus Cancer Care Center-Boise, Boise
  • Saint Alphonsus Cancer Care Center-Caldwell, Caldwell
  • Kootenai Health - Coeur d'Alene, Coeur d'Alene
  • 외 3개
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 3. 17. 업데이트됨 · NCT06418204

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Boise
피험자 모집 중관찰 연구
전 연령 · 모든 성별 · 2025. 10. 28. 업데이트됨 · NCT03452774

ClinicalTrials.gov 출처, 2026. 10. 6. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.